Focal Therapy Gains Ground in Low-Risk Prostate Cancer.
Charlie
C
Schmidt
D000726:Androgen Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood; D002318:Cardiovascular Diseases / Q000139:chemically induced; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy*; D018570:Risk Assessment; D012307:Risk Factors
D000726:Androgen Antagonists; D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen